<SEC-DOCUMENT>0001144204-12-032585.txt : 20120628
<SEC-HEADER>0001144204-12-032585.hdr.sgml : 20120628
<ACCEPTANCE-DATETIME>20120530173042
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-12-032585
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20120530

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synthetic Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		3985 RESEARCH PARK DRIVE,
		STREET 2:		SUITE 200
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48108
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		3985 RESEARCH PARK DRIVE,
		STREET 2:		SUITE 200
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48108

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19970730
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="image_001.gif" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">May 30, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>VIA EDGAR</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United States Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">100 F Street, NE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington, D.C. 20549</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">Jim Rosenberg</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">Senior Assistant Chief
Accountant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>Re:</I></B></TD><TD STYLE="text-align: justify"><B><I>Synthetic Biologics, Inc. (the &ldquo;Company&rdquo;)</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B><I>Form 8-K filed on May 3,
2012 and Form 8-K/A filed on May 30, 2012</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B><I>Item 4.02</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><B><I><U>File
No. 001-12584&#9;&#9;</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Rosenberg:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to
the above-captioned filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We acknowledge that
the adequacy and accuracy of the disclosure in our filings is our responsibility. We acknowledge that the staff comments or changes
to disclosure do not foreclose the Commission from taking any action with respect to the filings. We further acknowledge that the
Company may not assert staff comments as a defense in any proceedings initiated by the Commission or any person under the federal
securities laws of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">SYNTHETIC BIOLOGICS, INC.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 50%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline">/s/ C. Evan Ballantyne</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">C. Evan Ballantyne</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Chief Financial Officer</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #7E7E7E; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Synthetic Biologics, Inc.
3985 Research Park Drive, Suite 200, Ann Arbor, MI 48108 (t): 734-332-7800 (f): 734-332-7878</P>

<P STYLE="color: #7E7E7E; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="color: #7E7E7E; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="color: #7E7E7E; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=A3P'$`'<``"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P`
M````3P'$`(?___]"0D(Z.CKW]^_6UM[OYN_FG)1*2DKFSDK>4E*ME)SF$.:,
MI9SF&2EC4EK>UIS>G.;>G+TZ,4)*C!EC8UKFC`B]O<6$G._FE"G>$`CFUG.M
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M&0@9"`@(2EKF4LY*2H2M"$+F0@CFO0BM2@A2SHQS"$)S2@@9SHP9C`@9C$H9
MSDH9"(09S@BMSFOOUKU*:UI[K6NM:X1[K0BMQ92UQ>9",6-".AGF]__>]^]"
M0EK_]_]*.CI*0D((_P`!"!Q(L*#!@P@3*ES(L*'#AQ`C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMS)LZ?/GT"#"AU*
MM*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7KV##BAU+MJS9LVC3JEW+
MMJW;MW#CRIU+MZ[=NWCSZMW+MZ_?OX`#"QY,N+#APX@3*U[,N+'CQY`C2YY,
MN;+ERY@S:][,N;/GSZ!#BQY-NK3ITZA3JU[-NK7KU[!CRYY-N[;MV[ASZ][-
MN[?OW\"#"Q].O+CQX\B3*U_.O+GSY]"C2Y].O;KUZ]BS:]_.O;OW[^##B_\?
M3[Z\Z0'FOQ;8]\0*`2M/['C9I*B^%R_QXMD9P-]F`2M91`(%%`<XX``4D3#0
MQ!,%#%2`!5E<D443$EK1$`$13AAA$P50.*&$'"[TA(<4<C@BB"A^J"*)($9H
MH142MMB@0A@VD>&"`D&8(HLK[MB/C3L&V:.*#=8H8T(%=/B!@/(42`$45&3!
M8$H%C&A!B5<^$0\&S%2`P29<<LG,EXK@%P]Z,!60A0,!"."F`&V^Z68`D5@(
MP``,R#EG$PM9$:><5#SA@)X"?+`0`Z[(Z<`^B.J9J)R/OAFIFY'H$PFD`=B9
MT`=Z!L!G`0ZTX0^DCI8J`#]/_"FIJ:O*R2>GD_+_>5`3D?SICP0!J!H`%+*2
M5,![5P9K@056E)#?`UXH<@L&RR[KI9<8E!E/DBT]P<`!<^::*YRYWIJK/%GH
M`\`34+@I@;F1/('D!P'<*L"Y4*@K#Z$.9*%0%FV>*X`#!3"0;[8!Z*NMP-OJ
M^\$`G&;+CZ8(Y7FN!/[P8\&=Y08,,,$6<^NF/(*^^^;`%X?\KH7L#AS`Q`41
MP``4<6K;ILO<.O"!NB*-V(2P-Q.@\Q/[%,!?/!H@\(`&02/`+`9>,N-%"1&4
M,"-*!5RJ+9R$N@SQR3GZT^[4]B*$+\R>`@!JKKAN*T\_"?D[-;\*N/PRMV^#
M#/,'_7`Z]0$,'_2!UMOB_RWVO"];''C<,"\ZJ-QP4SWUX`)82(7B<.8=]:B)
MQPWWRY6"].#--P\+WQ,,#J!//V@6U,_I`]@!M!<(;!'!&[!'0$`!:)>4Y^"[
M?L```Q\0R"W?!Z"L]LNX]DJ0%6QN&S`#`A50<<%M1O)T05^;W:_;8&.O_0<%
MV$WUPH<J'O&GSU^N/?8."'I^X.9C3S+NQI-+N=L'#"A/\HRGZY'-PUY)`.C[
MJ-U$T%,`"$2@"Q[XP1LB0+N16.%J+X,"`0SR!*DI+Q+H01CZ)D@04"FN389J
MGCRT]KMM,6!Z`V%`V=K$+YMQCG/^.E<$F_!"&N+(;GW+FT$^L$(!^*T`%$B<
M//^N8,,KU="&-],'$FEHQ!$N#HE&O%F#2@8W33U!'BO$G!6>UJ%:0:Y0'7D"
MSHCUOP9>I!])*H$!89<,"U`+)$U07JZZ5A!]7!%RZ1,(`<H%.>XY2&V_DX>F
MG*<QY>W+>`/!E\86E1`_P<T?#!"70<3EO7:!3R$,&)6V#L"G`52,:OQ2B``5
MHH]/YNH`-&L8]F2E#WSQ[90,2"5!K(4]07*D?YW['P%$MY'3%4"-78#=&TH0
MDDPJSV\(N92<L":0X5&-DP-!7N44T$$G%C).TC-(VUPF#Q02)(YNHT+I=IBX
M`W!P4XL+WM_>M2TH>%,BGF0GG`X@2814$E=V(E?B!,#_@%&:3IG$0Z1%K-0Y
M]SRAGAU!XQ,,F`S8.6V<&<F"^4Z(T($\@8A(G)Z_+N<`*]B19>P[80?Y*,=M
M%0J%:L/5OF19$#^]#9+^)$@E<Z7#@CALDWSJARGWM0^,E/*#`7CG0'#(+91)
MU)`87,@^\)>K;&+D0<+Z7$]%<CH"'+"AP^R(!60()X@Y@`%;A.A"XLF^>"5L
M:NXL2`&<&$%LF91Y!,F"2MO4S818`&PAM&<Y"2!)].@#/:0#`!4TF2OP>1"M
M0H5(/#5V`+'*U'T"2=XS:TI!]\`'/AK9AQ4ZUX2=.3:A:&1:,-N86(D0<I\!
M<$`DHM2$L#)$FHO[@%O[AK*1_P),=V\[I`"KEZM0(L2EOV/`9P$P4SHQ0`&[
M0RYRC[NR:\H*<*!<8A&92,/9(81TY<M5:3<:.#[IHV6YBI=+K!2L)_ROHB$Y
M70FZ@%4&;N1K0/T3/Z#P`2FAER#Z,.;4"@DGN*HUB,J3TN':)0"G`D"%;ZLK
M0NY:-CA1(:9#K9P_*#>J"KM)DW!S`/FN62`'%*A`_/"P`T)\@+P>Y+1]&RYQ
M7TE3`+A4>1^XKTGL.*R;N<>Z5+)`!#P`.QQ?1(E,M1R+96:%SW9O<=C3GT$6
M2S;F$6"VN?(C`'B;6I8>KZ0'V]0UXR;#J\TU3OSX%(`OQ\[]=LM-4D:(*;6K
M$';!R?];$VM"@Y>G8I*0M[/_LW))^B%:V$&@S@_I%Q_CZS8'"_6*,K0<QQ"R
M5K[!J6O@?*M`MIDO!1_DKHOKIY;99\A.F\\??M,'@`G754YS*\N,SFYC94Q<
MR#8!<@&@(TO$R+D;ZWG/!4A&%T+P!C=JI!\`6E*35/5!.,ULP6Y-'#_"E>IL
M05(@^G#SMCIZ8/;E\;>+\X<X-SVX`WC[V^`^0-S&1S&@AOO<W@Y`FI=,TC8=
MH+14(%R<!R<!X8ZW?V0\+TIJ=SH#\O@-?P8`A"DB1@9$@DT`@QLTDWE-,"*)
MK;FBID"N^,H"`X#2WTHL@Y5G;[W&-@L,`+G(0QYRD.90;`/_GB?)1\[RD`O4
MMF]K;)L=W>*MODQKVVZ)/C9;WC(*!-`)76@$L*J`@`.=(&CBI5H'4'"6\3>M
M![FC2:_=['P%P+\N3G:[J#`\%B;6D8&CVZ;??,G3F?WLM^M6F`4R+XW%R^P"
M/SO<%_)3A9=6VMKZ%)0%(%Z&-.$#@`_\5#%"`&'IS`ZWGK$:8>>!Q"MDLT3$
M:&('$&GEW?JP9EM(HUTF\8%4'D[)4ZFE#8)IEW5<;^6D[%!)Z&X+$5)YHZ<(
M69^I8BIJRTX[9:9"3OLFWSZ5L[8N;4F>\+H0@$XB5RA0:@ND>H%(NZN472OD
MH%YU;F%=;&==7,P2#]QV24#L'O]>__,/;#[O'HYJU*\(D[4U^(-P5UO"(VR[
M#(P0`E@N_1>I,;',^S^7#"`"7P`!;A0"\1`1E,8MLG80&!<Y"*$^)@4%F@=Q
M`=!Y`_%D2#8UL4<0I:<MFN9Q)]=F6?1#%)!H?"=\#?%Z<?)N,R='^21N<?-R
M,E4Y"7@14$4L[/$_@W=T'=$!MM`!$3`)"=`@K-924)9:1880/Q4XC'1BT-4F
M^*=6)-5?E[9W2LA]RJ,UJ(9Z-W=):2,^:T=6M^(/',,?`^`S9EB&:&B&";%F
M*HA.E],K[Z<M]E4ZHD-+BB,!\G!.&F$S$T2&;S1K#9`!))`!&V``$!%MA'-U
MLY-!=F0%S_^S+296$$\P@@^H8IM7-A085^<C`!DX$!N8*QVHA7VCAWK30S\$
M.-O"#X&WBJRXBM'7;CY4>\J#3P[R?-/&`!;`(.W!`(-2<;JW$;^R(`,`!UOP
M`':P'RZ1``W0`!NP`0G@>`8!6R9#7\RU)/@3,QY5?4YHB6MV?;4(:U[72%>H
M;L-57..G`(_TA5&X->N#/3/X<VL65)B$.[7E8A940@,B(%#P#W,27-!($?N0
MBP.@!EJ0`@B@!OK!$@/P!<S8`"30`!&@@U.6B')R-5VE.-XX2RG'=T.X>=J2
MB01A?UNVA)<6,*8W<,152%QH3W($3?HP8.VX/E=0=2\C<YM"<YG_(HF#TG#]
MF$5N\H2_5@#Z8`?PH`4%B0`ID`+PL`6(]W,F$0$-8`L;$(@=()$`8`$FQTZL
MMV7R`(,.TH0"0`'<V(]7IQ!-(&X:LU+B>'/?5XZP-GYYPE@3@V+]2#59Y#;G
MPFR3M(X!T'[D-#@"Q2@N>',E!4HB-1)/P`9RP`8%J0%:X)CP@(PE@1[Q\`C+
MR(RV\(\'8054]#%4PRV1T`0H:5%8Y&A0T)$0)P'OJ(F&U(DY@CVA^)>CN!"V
M%P!^,P`22&:6$S>KB8+AB$Z"\XL=E`58]"?Z,B?RH`!^&1)VH`5L@`=&:90&
MF0*2Z2L&8`"VL(P9L(P%.!$!F06`IX\#_P)X"O($H_E-&9(%$U)G-J*>ZCE^
M(Q)R$K*>U[4/\^F>5H"2`.*>$P*-3\"?_9DC(>>>[:F>!7J?]YEX$`*@*@8C
MZCF?DX<AO".>D:`[6;!%)V$%<K"8<J`%\)`"'EJ0_2$2Z/$$8&"9EQF($8`1
M`W"#H1,<"@5``W">'P$'\&"CBLF8'XH`1:D!=C`C=(@1HU29V6D+V]D`AG@G
M&3&$O,&D)C&0>"`'T"F=(:H&U:D1XZ0/!I"B*IH>+S&,SKF8(0JB'FJ,)B@1
M^G`/(O`$'9"B&=`!9^*47IH2`V`%BAFET9FG\&"E';$/:S`']["E1VH+C_`%
M-#JG5`4'SXD'T/_)!A_*F!ZZI_O1('0X2D&J#_O@!@"@#_H@`FOPIX[P!->9
M'SYSJ)L*0*`CE!4Q)151)67DI`G1#SVC$:XZ.[!*2J!#`#USJY.4)%:)=#<X
MJP.59V?Z$<,8I2P@IO#`F)#*F&KP`$\PH@<Q2L20"'4@`L.0"&N@K7-0"6K*
M!XR@F=&46E!P/_)0CX<(!1GI$(YX($V2A1%!+J='$3MW/P-R`/,:KQ_@`/*P
MCTH&3X#'JVI5*P/R#\<V$=U3/P1RF"J1.O;PG%+*!LRZK,[)!G0`#S=JI7=P
MC-'J,ZES4/NP"&LP#'&P!G&@K8TP!HV0LAP0!0+K)V"U60@BK@9!`2#_Z1#[
MT#L+0@!-\%7%BE_D`GZK&@FAN8M0H`"F:CHKHP#_TP3TI72*Q3L_6Q"]DP7_
MDP7J.K6>>`!2@B$:IG/#"`]X``*,VJA:0`?.6;'/R9AT8`_P,`AJH`;V,`@/
MH`]ND`@GFZTE^Z>-P`%HP`&,,#H0805<N#(TBW1?-1$_HDX#H0!4!Q&"LJX0
M@2^:4C<.`+4/D2IZ.67K%FB`]ZL`8'\S"6T*`*\/P8L'=2>X"!-,UP3(*J6,
MNK826[%X(+$26[NURU<D&P>\6[)S,`<IN[*5(+@087_U5;KU4A%0L)IC1050
MT'[[P+4".W'JFK3)%`D%<5>'ZWFH=*J@,WX)_X$GG>L06="&`S&]%@4%%)`@
M\`&Z(?$$:C"V>#`!98N[MKNVM3L$<C`(`%`'O/NIGSH'?_J[<R`"%/%`#'`%
M5[`R]/<0_9"X`)M^@N*5"A&T/T:T+14`I$B^>51!Y2H!V]L\GSL1O#A.93A0
M?V<@%+P2`W`'36`/\\`"\RN_]<NH^BO#]K`/(;L()YL(<\"MC@`)]R!`UNLG
M%C"C_;`F*YP0R4D1:\(P%L"X\0K!%L$`BY9(W2L13^9=H',%.0E/4CL1?L(P
M(*>U`G$ST80@9DP2_&$'#S`/>+`"$S#'*P`"$\`"<XS'(!`$\P`'!^4&/,RM
MB>`&[BL0?G)./8NN#_^1O&+\5;43-5``NO)JO9OI#W1T19'X$$LE97@B`*D;
M$0ACN@XA*#%&O4D5$?T@(#,2;4`Y$W]E!U8`!_80QW%,OQ,@Q[A\R_8`LG6P
M"(Z@J4HZ$?:WO@+R5>ZKKA6!E?3U`4_RR8=(+JJ%(%`PNA)A`0=B<#.[JN/9
M.[4"O@<Q`%0PO@ZQ1\N<S1-!+LLL($M,$WUE!YI%`'`0RT]P!]&*N9QZ1CP#
M0&OL(/ML45F0BQ?!'J`#.H6L#Q@"T!8A+C:C+OWL,Q;1NCBRJ:M*0]Z,J#>!
MOD%APG**T1;-$!P-$ADT$"%])^+2'_SQ5Z*3TF*CI$DW$`)4R!WM$:533W_O
M)=$-XK%)4B4"724YC=,UO=+!3,DQC1(M+=(HG22Y:@4U9F-212V4*M$D?2="
M/=3I91"D$UAB\U?K(=#\IS-YUC,>&\R`9=54'1-H@C80U=*T(SKZ<(9L;=*2
M1+QR&LQE71-873M^)=9+5A`CW<]U/9E0#6T>74=_7=B&?=B(G=B*O=B,W=B.
M_=B0'=F2/=F47=F6?=F8G=F:O=F<W=F>_=F@'=JB/=JD7=JF?=JHG=JJO=JL
MW=JN_=JP'=NR/=NT7=NV?=NXG=NZO=N\W=N^_=O`'=S"/=S$7=S&?=S(G=S*
0O=S,W=S._=S0'=VL$1``.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
